Sunshine Biopharma announces commercial launch of doxycycline in Canada

Sunshine Biopharma (SBFM) announced the commercial launch of generic Doxycycline in Canada. This strategic move strengthens the Company’s footprint in the Canadian growing antibiotic sector. Doxycycline is now available to pharmacies, hospitals and healthcare providers nationwide. Doxycycline is a broad-spectrum antibiotic used to treat respiratory tract infections, urinary tract infections, sexually transmitted diseases, acne, and tick-borne illnesses such as Lyme disease. With high oral bioavailability and a long half-life, Doxycycline continues to be a first-line treatment across multiple antibacterial areas.